| Zefylti 30 MU/0.5 mL solution for injection/infusion in pre-filled syringe EU/1/24/1899/001-004 |
Filgrastim |
Curateq Biologics s.r.o. |
— |
| Zefylti 48 MU/0.5 mL solution for injection/infusion in pre-filled syringe EU/1/24/1899/005-008 |
Filgrastim |
Curateq Biologics s.r.o. |
— |
| Zegalogue 0.6 mg solution for injection in pre-filled syringe EU/1/24/1829/001-004 |
Dasiglucagon hydrochloride |
Zealand Pharma A/S |
— |
| Zejula 100 mg Capsule, hard EU/1/17/1235/001-003 |
Niraparib tosylate monohydrate |
GlaxoSmithKline Trading Services Limited |
— |
| Zejula 100 mg Film-coated tablet EU/1/17/1235/004-005 |
Niraparid tosylate monohydrate |
GlaxoSmithKline Trading Services Limited |
— |
| Zelboraf 240 mg film-coated tablets EU/1/12/751/001 |
Vemurafenib |
Roche Registration GmbH |
— |
| Zeliravel 400 microgram hard modified-release capsules PA23266/070/001 |
Tamsulosin hydrochloride |
Viatris Limited |
Not marketed |
| Zemcelpro = 0.23×106 viable CD34+ cells/mL/= 0.53×106 viable CD3+ cells/mL dispersion for infusion EU/1/25/1960/001 |
Haematopoietic stem cells and blood progenitor umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate |
Cordex Biologics International Limited |
— |
| Zemplar 1 microgram capsules, soft PA1824/005/001 |
Paricalcitol |
AbbVie Limited |
Marketed |
| Zemplar 2 micrograms capsules, soft PA1824/005/002 |
Paricalcitol |
AbbVie Limited |
Marketed |
| Zemplar 5 micrograms/ml solution for injection PA1824/005/004 |
Paricalcitol |
AbbVie Limited |
Marketed |
| ZEPATIER 50 mg/100 mg film-coated tablets EU/1/16/1119/001 |
Grazoprevir, Elbasvir |
Merck Sharp & Dohme BV, |
— |
| Zeposia 0.23 mg hard capsules Zeposia 0.46 mg hard capsules EU/1/20/1442/001 |
OZANIMOD |
Bristol-Myers Squibb Pharma EEIG |
— |
| Zeposia 0.92 mg hard capsules EU/1/20/1442/002-003 |
OZANIMOD |
Bristol-Myers Squibb Pharma EEIG |
— |
| Zerbaxa 1 g/0.5 g powder for concentrate for solution for infusion EU/1/15/1032/001 |
Ceftolozane sulfate, Tazobactam sodium |
Merck Sharp & Dohme BV, |
— |
| Zercepac 150 mg Powder for concentrate for solution for infusion EU/1/20/1456/001 |
Trastuzumab |
Accord Healthcare S.L.U. |
— |
| Zercepac 420 mg powder for concentrate for solution for infusion EU/1/20/1456/003 |
Trastuzumab |
Accord Healthcare S.L.U. |
— |
| Zercepac 60 mg powder for concentrate for solution for infusion EU/1/20/1456/002 |
Trastuzumab |
Accord Healthcare S.L.U. |
— |
| Zerlinda 4 mg/100 ml solution for infusion PA1986/119/001 |
Zoledronic acid |
Teva B.V. |
Marketed |
| Zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution PA1963/020/001 |
Ipratropium bromide monohydrate, Salbutamol |
Cipla Europe |
Not marketed |
| Zessly 100 mg powder for concentrate for solution for infusion EU/1/18/1280/001-005 |
Infliximab |
Sandoz GmbH |
— |
| Zestan 10 mg tablets PA0126/112/003 |
Lisinopril Dihydrate |
Clonmel Healthcare Ltd |
Marketed |
| Zestan 2.5mg Tablets PA0126/112/001 |
Lisinopril Dihydrate |
Clonmel Healthcare Ltd |
Marketed |
| Zestan 20 mg tablets PA0126/112/004 |
Lisinopril Dihydrate |
Clonmel Healthcare Ltd |
Marketed |
| Zestan 5mg Tablets PA0126/112/002 |
Lisinopril Dihydrate |
Clonmel Healthcare Ltd |
Marketed |
| Zestoretic 10 mg /12.5 mg Tablets PA22657/006/001 |
Lisinopril Dihydrate, Hydrochlorothiazide |
Atnahs Pharma Netherlands B.V. |
Marketed |
| Zestoretic 20 mg/12.5 mg Tablets PA22657/006/002 |
Hydrochlorothiazide, lisinopril anhydrous |
Atnahs Pharma Netherlands B.V. |
Marketed |
| Zestril 10 mg Tablets PA22657/007/002 |
Lisinopril |
Atnahs Pharma Netherlands B.V. |
Marketed |
| Zestril 20mg Tablets PA22657/007/003 |
Lisinopril |
Atnahs Pharma Netherlands B.V. |
Marketed |
| Zestril 5 mg Tablets PPA0465/066/005 |
Lisinopril |
PCO Manufacturing Ltd. |
— |
| Zestril 5mg Tablets PA22657/007/001 |
Lisinopril |
Atnahs Pharma Netherlands B.V. |
Marketed |
| Zevalin EU/1/03/264/001 |
Ibritumomabum tiuxetan |
Ceft Biopharma s.r.o |
— |
| Ziagen 20mg/mL Oral solution EU/1/99/112/002 |
Abacavir sulfate |
ViiV Healthcare BV |
— |
| Ziagen 300mg Film-coated table EU/1/99/112/001 |
Abacavir sulfate |
ViiV Healthcare BV |
— |
| Zibor 2,500 IU anti Xa/0.2 ml solution for injection in pre-filled syringes PA25279/001/001 |
Bemiparin sodium |
Gineladius S.L. |
Marketed |
| Zibor 25,000 IU anti-Xa/ml solution for injection in pre-filled syringes PA25279/001/003 |
Bemiparin sodium |
Gineladius S.L. |
Marketed |
| Zibor 3,500 IU anti Xa/0.2 ml solution for injection in pre-filled syringes PA25279/001/002 |
Bemiparin sodium |
Gineladius S.L. |
Marketed |
| Ziextenzo 6 mg solution for injection in pre-filled syringe EU/1/18/1327/001 |
Pegfilgrastim |
Sandoz GmbH |
— |
| Ziihera 300 mg powder for concentrate for solution for infusion EU/1/25/1931/001-002 |
Zanidatamab |
Jazz Pharmaceuticals Ireland Limited |
— |
| Zilbrysq 16.6 mg solution for injection in pre-filled syringe EU/1/23/1764/001-002 |
Zilucoplan |
UCB Pharma S.A. |
— |
| Zilbrysq 23 mg solution for injection in pre-filled syringe EU/1/23/1764/003-004 |
Zilucoplan |
UCB Pharma S.A. |
— |
| Zilbrysq 32.4 mg solution for injection in pre-filled syringe EU/1/23/1764/005-006 |
Zilucoplan |
UCB Pharma S.A. |
— |
| Zimbus Breezhaler 114 micrograms/46 micrograms/136 micrograms inhalation powder, hard capsules EU/1/20/1440/001-05 |
Indacaterol acetate, Glycopyrronium bromide, Mometasone furoate |
Novartis Europharm Limited |
— |
| Zimoclone 7.5 mg film-coated tablets PA23266/009/001 |
Zopiclone |
Viatris Limited |
Marketed |
| Zimovane 7.5 mg film-coated tablets PA23355/017/001 |
Zopiclone |
Viatris Healthcare Limited |
Marketed |
| Zinacef 1.5 g powder for solution for injection or infusion PA23311/002/003 |
Cefuroxime Sodium |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinacef 250 mg powder for solution for injection or infusion PA23311/002/001 |
Cefuroxime Sodium |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinacef 750 mg powder for solution for injection or infusion PA23311/002/002 |
Cefuroxime Sodium |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinc & Castor Oil Ointment Zinc Oxide 7.5%w/w Castor Oil 50%w/w PA0206/027/001 |
Zinc oxide, Castor oil |
Ovelle Limited |
Marketed |
| Zinc 15% w/w Ointment PA0206/028/001 |
Zinc oxide |
Ovelle Limited |
Marketed |